This is a non-core endpoint: only basic statistics are computed.
Other benign neoplasm of uterus: Corpus uteri
CD2_BENIGN_CORPUS_UTERI_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D26
- Name in latin
- Neoplasma benignum corporis uteri
Similar endpoints
↥List of similar endpoints to
Other benign neoplasm of uterus: Corpus uteri
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasm of uterus: Corpus uteri
- Other benign neoplasms of uterus
- Other benign neoplasms of uterus
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 263 | 263 | - |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | - |
| Median age at first event (years) | 47.49 | 47.49 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 231
- Matched controls
- 2309
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D26.1
ICD-10 Finland
Other benign neoplasm: Corpus uteri
+∞
198.8
161
*
2191A
ICD-9 Finland
Other benign neoplasm of uterus, Corpus uteri
+∞
77.5
70
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
6.1
17.7
51
102
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
H02AB02
ATC
dexamethasone; systemic
24.2
14.5
20
9
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.7
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.7
13
*
A04AA02
ATC
granisetron; systemic, transdermal
148.3
13.6
14
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.6
12.8
67
237
LCD00
NOMESCO Finland
Hysterectomy
5.4
12.7
39
83
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.6
12
*
L02BG04
ATC
letrozole; oral
18.5
9.5
14
8
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
104.1
9.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
3.4
9.4
48
165
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
4.6
8.2
28
67
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
3.1
7.8
45
168
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8305
FHL
Supravaginal amputation or resection
6.4
7.2
18
30
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.0
6.3
36
134
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
WX704
NOMESCO Finland
Intubation
3.8
6.1
25
72
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
135
960
1.83
5.50
4.6
3.5
—
—
—
0
0
30
120
2.69
5.43
5.1
1.3
2.9
2.7
ug/l
0.19
25
93
18
62
3.04
4.26
5.1
3.2
25.9
25.3
mmol/l
0.34
18
57
101
705
1.70
4.07
2.4
2.1
55.3
55.4
u/l
0.02
95
631
98
688
1.68
3.82
3.7
2.5
33.8
28.3
u/l
0.87
90
650
18
67
2.81
3.74
1.3
1.4
—
—
—
0
0
119
889
1.62
3.57
6.1
3.4
34.8
36.2
g/l
1.98
113
825
155
1244
1.60
3.39
4.0
3.8
6.5
6.6
mmol/l
0.09
143
1145
139
1102
1.55
3.10
7.9
4.9
1.2
1.2
mmol/l
1.55
123
948
10
29
3.55
3.08
1.3
1.2
—
—
—
0
0
197
1696
1.64
3.04
8.9
5.1
83.3
74.8
u/l
1.72
192
1541
127
994
1.54
2.96
6.3
4.4
1.2
1.2
mmol/l
1.53
116
872
8
18
4.55
2.81
2.3
2.3
27.6
17.5
u/ml
—
8
18
76
537
1.58
2.76
2.5
2.2
2.8
3.1
mg/l
0.73
66
441
143
1160
1.51
2.75
9.7
6.5
4.0
4.1
e9/l
0.09
129
1006
66
453
1.61
2.70
2.5
2.0
—
—
—
0
0
20
93
2.25
2.68
1.4
1.5
—
—
—
0
0
51
328
1.69
2.68
5.0
4.8
35.4
34.0
%
0.36
31
200
97
741
1.49
2.42
4.3
2.0
2.4
2.4
mmol/l
0.11
74
612
14
59
2.45
2.33
1.5
1.4
—
—
—
0
0
6
13
4.70
2.28
1.0
1.2
6.3
5.6
mmol/l
—
6
13
39
244
1.70
2.27
5.8
3.9
1.1
1.0
mmol/l
0.80
32
214
12
50
2.47
2.05
5.5
1.3
44.7
33.2
mg/l
0.56
12
41
12
50
2.47
2.05
5.5
1.3
21.8
26.6
mg/l
0.37
12
41
11
45
2.51
1.95
1.4
1.9
—
—
—
0
0
8
28
2.91
1.88
1.4
1.1
—
—
—
0
0
8
29
2.81
1.80
1.4
1.1
—
—
—
0
0
8
29
2.81
1.80
1.4
1.1
—
—
—
0
0
8
31
2.63
1.67
1.4
1.1
—
—
—
0
0
8
31
2.63
1.67
1.3
1.4
—
—
—
0
0
8
31
2.63
1.67
1.4
1.1
—
—
—
0
0
8
31
2.63
1.67
1.4
1.1
—
—
—
0
0
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
66
503
1.42
1.60
1.7
1.7
685714715.9
12531794.6
pmol/l
1.36
56
399
13
64
2.08
1.57
1.0
1.1
—
12.1
—
0
7
80
638
1.36
1.48
2.6
2.7
1010.7
1040.3
ng/l
0.03
59
530
159
1405
1.33
1.47
3.7
2.8
59.3
39.6
u/l
1.29
150
1285
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
12
60
2.05
1.40
1.3
1.2
—
—
—
0
0
7
29
2.45
1.40
1.3
1.2
—
—
—
0
0
5
17
2.98
1.36
5.0
2.1
—
—
—
0
0
58
445
1.39
1.35
1.8
1.7
1192.7
1177.6
nmol/l
0.05
44
316
18
106
1.75
1.33
2.1
1.6
—
—
—
0
0
25
162
1.60
1.31
3.8
1.3
65.1
68.1
g/l
0.75
18
143
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
6
24
2.53
1.31
1.5
1.4
—
—
—
0
0
13
69
1.93
1.31
4.8
1.2
2.9
3.0
g/l
—
5
58
9
44
2.08
1.28
1.4
1.7
226.9
324.6
mu/l
—
9
39
22
139
1.64
1.28
1.5
1.4
—
—
—
0
0
9
45
2.03
1.24
1.0
1.4
—
—
—
0
0
238
2266
1.53
1.21
15.4
11.2
19.2
19.3
mg/l
0.02
195
1705
31
216
1.49
1.20
6.0
5.2
1.7
1.8
mmol/l
0.12
21
168
191
1759
1.31
1.17
4.7
4.4
14.6
12.1
mm/h
1.24
174
1610
38
278
1.43
1.16
3.0
2.3
2.4
2.4
g/l
0.09
32
253
100
851
1.28
1.14
3.2
3.4
19.0
66.5
ng/l
0.58
68
574
10
51
2.00
1.12
1.5
1.2
—
—
—
0
0
10
51
2.00
1.12
2.8
1.6
31484.8
5027.3
u/l
—
5
20
5
21
2.41
1.09
1.0
1.5
38.1
47.7
u/l
—
5
15
13
74
1.80
1.09
4.0
1.2
8.1
11.2
g/l
—
5
65
10
52
1.96
1.07
1.1
1.2
—
—
—
0
0
253
2453
1.83
1.06
12.6
9.0
26.1
23.5
u/l
0.79
242
2342
13
75
1.77
1.05
3.1
4.1
24.4
24.7
mmol/l
0.21
13
64
41
312
1.37
1.02
4.5
6.8
—
—
—
0
0
13
76
1.75
1.01
4.8
1.2
3.1
4.0
g/l
—
5
57
13
76
1.75
1.01
4.8
1.2
—
—
—
0
0
13
76
1.75
1.01
4.8
1.2
6.2
7.5
g/l
—
6
57
40
304
1.37
1.00
2.0
1.8
—
—
—
0
0
72
597
1.28
0.99
4.1
4.2
0.0
0.0
estimate
0.00
17
203
6
27
2.25
0.94
1.7
1.3
—
—
—
0
0
226
2346
0.74
0.88
5.1
4.8
5.9
5.9
mmol/l
0.05
202
2139
8
44
1.84
0.86
2.3
2.5
—
—
—
0
0
40
312
1.33
0.86
3.1
2.2
12.7
13.5
umol/l
0.34
33
280
6
31
1.96
0.85
2.3
1.3
—
—
—
0
0
250
2431
1.57
0.82
17.8
13.2
71.1
69.9
umol/l
0.22
250
2431
101
889
1.22
0.82
4.9
4.1
—
—
—
0
0
64
536
1.26
0.81
3.8
2.1
331.2
6142.5
umol/l
2.53
50
450
12
76
1.61
0.73
1.3
1.6
—
232.0
—
0
5
28
213
1.35
0.72
1.8
1.8
—
—
—
0
0
10
61
1.66
0.69
1.6
1.2
32.9
38.7
g/l
—
5
54
245
2382
1.42
0.69
17.5
13.4
139.8
140.0
mmol/l
0.57
237
2312
142
1307
1.19
0.69
3.0
2.8
—
—
—
0
0
32
251
1.31
0.68
3.6
2.4
20.8
23.4
%
0.61
24
208
5
28
1.80
0.66
2.8
2.5
13.8
13.2
%
—
5
28
11
70
1.60
0.66
2.2
1.6
—
—
—
0
0
214
2221
0.80
0.65
6.6
6.0
39.6
39.4
mmol/mol
0.14
189
2053
16
113
1.44
0.62
2.0
1.4
—
—
—
0
0
245
2388
1.38
0.61
17.8
13.5
4.0
3.9
mmol/l
0.40
237
2312
11
72
1.55
0.60
2.3
1.8
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
10
64
1.58
0.59
1.1
2.0
520.8
189.9
ug/l
—
10
56
6
36
1.68
0.57
1.0
1.6
—
—
—
0
0
6
36
1.68
0.57
1.0
1.6
—
—
—
0
0
6
37
1.64
0.56
1.8
1.5
—
—
—
0
0
15
204
0.72
0.55
6.6
2.9
—
—
—
0
0
27
214
1.29
0.55
1.9
1.8
—
—
—
0
0
9
64
1.42
0.52
2.8
1.4
—
—
—
0
0
6
40
1.51
0.52
1.3
1.3
—
—
—
0
0
115
1060
1.15
0.51
3.0
2.3
79.0
80.6
nmol/l
0.28
99
936
112
1031
1.15
0.50
2.5
2.0
100.5
99.1
pmol/l
0.11
63
457
125
1162
1.14
0.48
6.4
5.4
0.0
0.0
estimate
0.00
16
198
58
509
1.18
0.48
2.1
1.6
1.2
0.9
mg/l
0.65
48
390
124
1153
1.14
0.48
4.4
3.9
0.0
0.0
estimate
0.00
17
202
126
1173
1.14
0.47
4.5
3.9
0.0
0.0
estimate
0.50
17
200
49
562
0.84
0.47
3.6
3.0
0.2
0.4
e6/l
1.30
40
423
228
2337
0.82
0.47
5.1
4.7
1.6
1.6
mmol/l
0.21
202
2140
29
350
0.81
0.47
3.1
2.5
1.3
1.4
e6/l
0.10
19
193
7
49
1.44
0.46
2.7
1.4
—
—
—
0
0
62
550
1.17
0.45
1.6
1.4
—
—
—
0
0
12
86
1.41
0.45
1.3
2.3
—
—
—
0
0
26
212
1.25
0.44
6.7
4.1
103.6
103.7
mmol/l
0.04
26
204
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
231
2356
0.84
0.36
4.9
4.7
4.9
4.8
mmol/l
0.36
207
2160
61
551
1.14
0.36
1.2
1.3
0.7
2.6
u/ml
—
8
140
230
2249
1.18
0.35
5.7
5.4
1.8
2.4
mu/l
0.60
192
2062
32
278
1.17
0.31
2.4
1.6
28.1
29.1
s
0.41
32
267
36
408
0.86
0.31
1.4
1.5
—
—
—
0
0
202
1964
1.12
0.31
4.6
4.5
14.5
14.8
pmol/l
1.05
171
1797
53
482
1.12
0.28
1.3
1.3
15.3
15.5
u/ml
0.01
17
165
8
62
1.30
0.28
1.3
1.2
—
—
—
0
0
8
62
1.30
0.28
1.4
1.3
—
15.5
—
0
6
8
65
1.24
0.27
2.4
1.7
—
—
—
0
0
21
180
1.18
0.24
7.8
5.5
111.9
121.1
g/l
1.25
21
174
10
78
1.29
0.24
1.4
1.2
25.5
28.8
iu/l
—
10
63
6
82
0.73
0.24
1.0
1.2
—
—
—
0
0
6
82
0.73
0.24
1.0
1.2
—
—
—
0
0
54
585
0.90
0.24
2.1
1.5
19.9
22.7
nmol/l
0.81
44
492
52
478
1.11
0.24
1.3
1.3
18.7
36.0
iu/ml
1.06
14
155
15
178
0.83
0.22
1.5
1.9
—
—
—
0
0
28
314
0.88
0.22
3.0
2.8
6.9
5.0
e6/l
0.26
18
160
209
2048
1.10
0.22
18.3
12.9
38.9
39.3
%
0.31
131
1376
5
41
1.22
0.22
1.4
1.3
—
—
—
0
0
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
9.9
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
11
134
0.81
0.21
1.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
15
175
0.85
0.19
2.1
1.6
—
—
—
0
0
214
2175
0.91
0.19
14.3
10.2
76.5
78.5
ml/min/173m2
0.63
152
1695
221
2243
0.91
0.19
4.3
4.2
1.3
1.2
mmol/l
1.55
199
2028
8
72
1.11
0.16
2.3
1.5
—
—
—
0
0
14
161
0.86
0.15
1.4
1.8
—
—
—
0
0
9
78
1.16
0.15
1.2
1.3
—
3.2
—
0
16
12
102
1.18
0.15
9.8
5.2
88.5
93.4
%
0.35
12
102
13
112
1.17
0.14
1.8
1.4
—
—
—
0
0
237
2392
0.91
0.13
5.4
5.3
2.9
2.8
mmol/l
0.61
212
2188
75
721
1.06
0.12
1.7
2.0
125.3
144.6
u/l
0.41
69
680
103
1003
1.04
0.10
3.8
2.8
99.6
85.5
ug/l
0.54
96
913
9
86
1.05
0.07
1.4
1.7
—
—
—
0
0
18
193
0.93
0.06
1.3
1.2
264.5
122.6
iu/ml
—
10
86
71
724
0.97
0.04
4.0
3.1
—
—
—
0
0
44
430
1.03
0.03
3.3
4.0
14.1
161.9
ng/l
2.69
29
322
17
176
0.96
0.00
2.6
2.3
1.2
1.2
mmol/l
0.21
17
141
10
101
0.99
0.00
2.5
2.1
1.2
1.2
%
—
10
101
70
701
1.00
0.00
1.7
1.7
1.3
1.3
mmol/l
0.02
55
596
11
105
1.05
0.00
1.5
1.4
—
—
—
0
0
13
125
1.04
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
376.1
—
0
7
5
50
1.00
0.00
1.4
1.3
0.5
0.9
nmol/l
—
5
36
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
1.2
—
0
6
0
5
0.00
0.00
0.0
1.6
—
42.8
—
0
5
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
9
90
1.00
0.00
7.4
4.6
25.4
25.5
mmol/l
—
9
90
5
58
0.86
0.00
1.0
1.2
4.0
3.9
mmol/l
—
5
52
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CORPUS_UTERI_EXALLC – Other benign neoplasm of uterus: Corpus uteri
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).